BioPharm International
December 01, 2007
Features
20
12
How the authors used design of experiments and quality by design principles to develop a hydrophobic interaction chromatography step.
December 01, 2007
Features
20
12
The second of a two part article.
December 01, 2007
Features
20
12
Developing a process validation strategy early in clinical development is critical for a successful validation program.
December 01, 2007
Columns and Departments
20
12
China's pharma industry represents 5% of the world total. By 2010, China is expected to become the world's fifth largest pharmaceutical market.
December 01, 2007
Columns and Departments
20
12
Eighty drugs will lose patent protection between 2007 and 2011.
December 01, 2007
Columns and Departments
20
12
Many companies acknowledged that Western regulatory standards are tougher than those in China.
December 01, 2007
Columns and Departments
20
12
More than $1 out of every $9 under professional management in the United States is involved in socially responsible investing.
December 01, 2007
Columns and Departments
20
12
The personalized medicine bandwagon is on a roll, offering a new model for calculating reimbursement of high-cost biotech therapies. Strategies for identifying patients who will respond to a certain therapy, as well as those most likely to suffer adverse events, promise to improve healthcare quality while eliminating waste and inappropriate spending. Interventions based on individual genetic characteristics may have limited sales, but support higher prices and less costly clinical research methods.